Dan Peer

This inventor holds 23 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 11 EPO patents, primarily in Nucleic Acid Delivery. Top assignees: Tel Aviv University, B.g. Negev Technologies and Applications Ltd., Quiet Therapeutics Ltd.. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dan Peer. Retrieved from https://idiyas.com/inventor/dan-peer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 12)

% Patents Active = 69.6

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 17)

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 31(Granted Patents)

Location History:

Kiryat Uno, IL (2013)
Qiryat Ono, IL (2009 - 2016)
Qirylat Ono, IL (2016)
Kiryat Ono, IL (2003 - 2024)

Company Filing History:

B.g. Negev Technologies and Applications Ltd.

patents

1 out of 1

Quiet Therapeutics Ltd.

patent

where one patent can have more than one assignee

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

Targeted Therapeutics

Nucleic Acid Delivery

Lipid Particles

Immunoparticles

Cell-Targeting Nanoparticles

Liposomal Formulations

Cationic Lipids

Polynucleotide Agents

Drug Delivery

Gene Delivery

Glycosaminoglycan Particles

RNA Transfection

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12668643 - MODULAR PLATFORM FOR TARGETED THERAPEUTICS (2026-06-30),

2. 12616662 - LIPID PARTICLES FOR NUCLEIC ACID DELIVERY AND CLINICAL APPLICATIONS OF SAME (2026-05-05),

3. 12514957 - Omentum based scaffold and delivery system (2026-01-06),

4. 12065664 - Method for treatment of a leukocyte related disease by delivery of nucleic acid molecules to leukocytes using targeted lipid particles (2024-08-20),

5. 11851389 - Cationic lipids for nucleic acid delivery and preparation thereof (2023-12-26),

6. 11708421 - Modular platform for targeted therapeutics (2023-07-25),

7. 11338042 - Immunoparticles and methods of generating and using same (2022-05-24),

8. 10920246 - Targeted lipid particles for systemic delivery of nucleic acid molecules to leukocytes (2021-02-16),

9. 10583084 - Liposomal formulations for delivery of nucleic acids (2020-03-10),

10. 10543278 - Immunoparticles and methods of generating and using same (2020-01-28),

11. 10179113 - Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof (2019-01-15),

12. 9925143 - Lipidated glycosaminoglycan particles for the delivery of nucleic acids (2018-03-27),

13. 9574210 - Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof (2017-02-21),

14. 9566346 - Positively charged polysaccharides for RNA transfection (2017-02-14),

15. 9526705 - Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy (2016-12-27),

Title: The Innovative Journey of Dan Peer

Introduction: Dan Peer, a distinguished inventor hailing from Kiryat Ono, Israel, has made significant contributions to the field of innovation through his groundbreaking work in various patents.

Latest Patents: Dan Peer's recent patents showcase his commitment to pushing the boundaries of science and technology, with a focus on advancements in healthcare, biotechnology, and pharmaceuticals.

Career Highlights: Throughout his illustrious career, Dan Peer has been recognized for his pioneering research in drug delivery systems, nanomedicine, and personalized medicine. His innovative approaches have revolutionized the way treatments are administered and have led to improved outcomes for patients worldwide.

Collaborations: Dan Peer has collaborated with leading researchers, scientists, and institutions globally to further his research and bring his inventions to life. His partnerships have been instrumental in driving forward the field of biotechnology and establishing him as a key figure in the industry.

Conclusion: Dan Peer's relentless pursuit of innovation and his passion for improving healthcare have cemented his legacy as a visionary inventor. His work continues to inspire future generations of inventors and researchers to push the boundaries of what is possible in the world of science and technology.

Profile summary based on public USPTO records.